Today: 29 April 2026
Browse Category

NYSE:MOH 23 October 2025 - 9 March 2026

Lumentum Holdings Stock Jumps as S&P 500 Addition Extends Nvidia-Linked AI Optics Rally (News Release Archive)

Lumentum Holdings Stock Jumps as S&P 500 Addition Extends Nvidia-Linked AI Optics Rally (News Release Archive)

Lumentum shares rose 10.6% to $617.81 in New York trading after S&P Dow Jones Indices said it will add the company to the S&P 500 on March 23. The move follows Nvidia’s $2 billion investment and a multiyear purchase agreement announced last week. Peers Coherent and Vertiv also gained. Lumentum reported second-quarter revenue up 65.5% to $665.5 million and forecast third-quarter revenue of up to $830 million.
UnitedHealth stock price today: UNH ticks up as Medicare Advantage rates and U.S. data loom

UnitedHealth stock price today: UNH ticks up as Medicare Advantage rates and U.S. data loom

UnitedHealth shares rose 0.3% to $277.44 in late morning trading Monday after CMS signaled a 0.09% Medicare Advantage payment increase for 2027. The stock remains under pressure after a 19% drop on Jan. 27, when the company warned of its first revenue decline since 1989. U.S. stocks were mixed, with the Dow down 0.3%. Comments on the CMS proposal are due by Feb. 25.
9 February 2026
Healthcare stocks in focus: Molina shock, FDA “copycat” warning and XLV set up Monday’s trade

Healthcare stocks in focus: Molina shock, FDA “copycat” warning and XLV set up Monday’s trade

Molina Healthcare plunged 25.5% after forecasting 2026 profit far below estimates and announcing a 2027 exit from Medicare Part D. Centene guided profit above expectations but dropped 3.7%, while Cigna rose 2.6% on a strong quarter but flagged a softer 2026 outlook. XLV gained 1.8%. Hims fell 10% after the FDA warned against mass-marketing compounded obesity drugs.
7 February 2026
UnitedHealth stock rebounds after hours as UNH recoups losses; Medicare rate debate looms

UnitedHealth stock rebounds after hours as UNH recoups losses; Medicare rate debate looms

UnitedHealth shares rose 3.4% to $277.57 Friday and gained another 3% after hours, rebounding after a volatile week for health insurers. Mizuho cut its price target on the stock to $350, citing delayed earnings recovery. Medicare Advantage rates and medical-cost trends remain key concerns. The Dow closed above 50,000, marking the strongest market gains in months.
Dow Jones breaks 50,000 for first time as Nvidia rebounds; Wall Street turns to delayed jobs report

Dow Jones breaks 50,000 for first time as Nvidia rebounds; Wall Street turns to delayed jobs report

The Dow Jones Industrial Average closed above 50,000 for the first time Friday, ending at 50,115.67, up 2.47%. Nvidia surged 7.8% as chip stocks rallied on AI spending hopes, while Amazon dropped 5.6% after projecting $200 billion in 2026 capital expenditures. Traders await delayed U.S. jobs and inflation reports next week.
Molina Healthcare stock dives 27% after 2026 profit outlook reset; Medicare Advantage exit looms

Molina Healthcare stock dives 27% after 2026 profit outlook reset; Medicare Advantage exit looms

Molina Healthcare shares plunged 27% to $129.77 after the company forecast 2026 adjusted EPS of at least $5.00, far below the $13.76 analyst consensus. Management cited higher medical costs and a sharp pullback in ACA Marketplace membership. The company posted a Q4 adjusted loss of $2.75 per share and plans to exit its Medicare Advantage Part D business in 2027.
6 February 2026
Oscar Health (OSCR) stock slips again in premarket as insurer cost fears spread ahead of earnings

Oscar Health (OSCR) stock slips again in premarket as insurer cost fears spread ahead of earnings

Oscar Health shares fell 2.3% to $12.22 in premarket trading Friday after a 5.4% drop Thursday, as investors reacted to Molina Healthcare’s profit warning and exit from Medicare Part D. Molina’s stock plunged nearly 35% after hours, dragging other managed-care stocks lower. Oscar reports earnings Feb. 10, with investors watching for updates on 2026 enrollment and claims.
Molina Healthcare Stock (NYSE: MOH) News on Dec. 12, 2025: Rally Extends as ACA Subsidy Deadline, 2026 Outlook, and Analyst Forecasts Collide

Molina Healthcare Stock (NYSE: MOH) News on Dec. 12, 2025: Rally Extends as ACA Subsidy Deadline, 2026 Outlook, and Analyst Forecasts Collide

Molina Healthcare shares traded near $169.53 on Dec. 12, 2025, following an eighth straight session of gains. The stock’s rebound comes after a steep drop earlier in the year, with shares still well below the April high of $359.97. A new diabetes care partnership in South Carolina and renewed ACA policy uncertainty have influenced recent trading.
12 December 2025
MOH Stock Today, Nov. 24, 2025: Molina Healthcare Rallies on ACA Subsidy Hopes as Lawsuits and Margin Pressures Linger

MOH Stock Today, Nov. 24, 2025: Molina Healthcare Rallies on ACA Subsidy Hopes as Lawsuits and Margin Pressures Linger

Molina Healthcare shares closed up 2.6% at $145.30 Monday on heavy volume after reports of a possible extension of ACA subsidies. The stock remains down over 50% from its 52-week high following an October earnings shock and ongoing class-action lawsuits. Market cap stood at $7.5 billion, with a P/E ratio near 9x. Intraday trading ranged from $141 to $151.
24 November 2025

Stock Market Today

  • Avantis International Equity ETF (AVDE) Sees $188M Inflows, Shell, HSBC, Novartis Impacted
    April 29, 2026, 11:45 AM EDT. The Avantis International Equity ETF (AVDE) experienced a significant $188.1 million inflow, marking a 2.2% rise in outstanding units week over week. Key underlying holdings include Shell plc (SHEL), which dipped 0.9%, HSBC Holdings plc (HSBC) up 0.7%, and Novartis (NVS) gaining 0.2%. AVDE's share price stands near its 52-week high at $76.43, close to the peak of $76.79, with a 52-week low at $58.56. The ETF creation process, involving issuance of new units, drives the purchase of underlying assets, affecting component stocks. Monitoring changes in ETF units offers insight into market demand and potential stock movements within funds.

Latest article

Cognizant Stock Drops As Weak Revenue Outlook Overshadows $600 Million AI Deal

Cognizant Stock Drops As Weak Revenue Outlook Overshadows $600 Million AI Deal

29 April 2026
TEANECK, N.J., April 29, 2026, 11:02 EDT Cognizant Technology Solutions Corp shares fell on Wednesday after the IT services company forecast second-quarter revenue below Wall Street estimates, a warning that cautious client spending is still pressing the sector even as companies push money into artificial intelligence. The stock recently traded at $53.45, down $1.67 in New York trading. (Reuters) The outlook matters because Cognizant is trying to sell investors two stories at once: demand for AI-led technology work is rising, but traditional discretionary technology budgets remain tight. The company expects second-quarter revenue of $5.45 billion to $5.52 billion, below analysts’
ON Semiconductor Stock Jumps as Geely and NIO Deals Put 900V EV Chips in Focus

ON Semiconductor Stock Jumps as Geely and NIO Deals Put 900V EV Chips in Focus

29 April 2026
ON Semiconductor shares jumped 8% Wednesday after announcing expanded silicon carbide chip deals with Geely Auto Group and NIO Inc., both focused on 900-volt electric vehicle platforms. The company’s market value reached about $41.2 billion ahead of first-quarter results due May 4. Investors are watching whether new auto-chip wins can offset uneven demand.
NXP Stock Jumps 25% as Auto Chip Rebound Powers a Forecast Beat

NXP Stock Jumps 25% as Auto Chip Rebound Powers a Forecast Beat

29 April 2026
NXP Semiconductors shares jumped up to 25% Wednesday after the company forecast second-quarter revenue and profit above Wall Street expectations. First-quarter revenue rose 12% to $3.18 billion, with automotive sales up 6% and industrial and IoT revenue up 24%. NXP guided Q2 revenue to $3.35–$3.55 billion and adjusted earnings to $3.29–$3.72 per share. Data-center-related revenue is projected to surpass $500 million in 2026.
Go toTop